NCT07335718 Evaluation of the Effectiveness of Focused Radiofrequency (TECAR) Therapy on Pain, Disability, Function, and Quality of Life in Patients With Lumbar Disc Herniation
| NCT ID | NCT07335718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Lumbar Disc Herniation |
| Study Type | OBSERVATIONAL |
| Enrollment | 54 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 54 participants in total. It began in 2025-01-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Low back pain is a very common health problem in societies, regardless of the underlying cause. Its lifetime prevalence has been reported to be as high as 75-80%. Low back pain negatively affects the quality of life of affected individuals. In addition to diagnostic and treatment costs, it can lead to serious physical disability, resulting in loss of workforce and placing a substantial economic burden on countries. Many different factors play a role in the etiology of low back pain. According to etiology, it can be classified as idiopathic, mechanical, rheumatologic, metabolic, endocrine, infectious, neoplastic, neurologic/psychiatric disorders, and pain of visceral origin. The treatment of low back pain can be classified into medical treatment, physical therapy, percutaneous invasive interventions, and surgical intervention. TECAR therapy is also one of the treatment modalities routinely used in clinical practice. Our aim is to develop more effective physical therapy programs.
Eligibility Criteria
Inclusion Criteria: * Having low back pain lasting longer than 12 weeks Having a diagnosis of lumbar disc herniation (bulging, protruded, or extruded) Being able to comply with the exercise program Willingness to participate in the study Being between 20 and 60 years of age Exclusion Criteria: Being younger than 20 years or older than 60 years Having a known and/or newly diagnosed malignancy Presence of cardiac implants such as a pacemaker Having inflammatory low back pain Having absolute spinal stenosis (anteroposterior diameter of the spinal canal \< 10 mm and anteroposterior diameter of the lateral recess \< 3 mm) History of surgery due to lumbar disc herniation, lumbar spinal stenosis, vertebral fracture, or similar conditions Presence of lumbar spondylolisthesis Patients with sequestered disc herniation Patients with polyneuropathy Patients with central pain following stroke Patients with neurological deficits Having a diagnosed neurodegenerative disease Having a systemic musculoskeletal disease Patients with acute deep vein thrombosis Pregnancy Presence of infection at the skin surface where treatment will be applied Unexplained weight loss Bladder and/or bowel incontinence Having received physical therapy modalities or injections for low back pain within the last 1 month Having cognitive impairment Refusal to participate in the study \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07335718 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Lumbar Disc Herniation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07335718 currently recruiting?
Yes, NCT07335718 is actively recruiting participants. Contact the research team at saymazcemre@gmail.com for enrollment information.
Where is the NCT07335718 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07335718 clinical trial?
NCT07335718 is sponsored by Ankara City Hospital Bilkent. The trial plans to enroll 54 participants.